Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:41 pm Purchase | 2025-03-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Armistice Capital, LLC | 9,235,571 9.990% | 8,312,014 (+900.00%) | Filing History |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 148,148 1.600% | -324,967 (-68.69%) | Filing History |
| 2025-05-15 3:20 pm Purchase | 2025-03-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Armistice Capital, LLC | 923,557 9.990% | 10,075 (+1.10%) | Filing History |
| 2025-02-14 5:01 pm Purchase | 2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Armistice Capital, LLC | 913,482 9.990% | 913,482 (New Position) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 473,115 5.100% | -323,100 (-40.58%) | Filing History |
| 2025-02-12 4:05 pm Purchase | 2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Caligan Partners LP | 1,585,665 9.990% | 1,585,665 (New Position) | Filing History |
| 2024-12-09 6:22 pm Purchase | 2024-12-05 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 796,215 8.700% | 86,297 (+12.16%) | Filing History |
| 2024-11-26 4:15 pm Purchase | 2024-11-22 | 13D | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 5,250,405 49.900% | 3,711,457 (+241.17%) | Filing History |
| 2024-11-14 09:32 am Sale | 2024-09-30 | 13G | Verrica Pharmaceuticals Inc. VRCA | Avoro Capital Advisors LLC | 0 0.000% | -658,333 (Position Closed) | Filing History |
| 2024-02-14 4:47 pm Purchase | 2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 709,918 16.900% | 206,020 (+40.89%) | Filing History |
| 2024-02-14 09:10 am Purchase | 2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Avoro Capital Advisors LLC | 658,333 9.990% | 658,333 (New Position) | Filing History |
| 2023-02-14 2:37 pm Purchase | 2022-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 503,898 12.300% | 142,857 (+39.57%) | Filing History |
| 2022-07-15 4:15 pm Purchase | 2022-07-05 | 13D | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 1,538,948 37.400% | 476,190 (+44.81%) | Filing History |
| 2022-02-14 4:37 pm Purchase | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 1,062,758 38.600% | 78,983 (+8.03%) | Filing History |
| 2022-02-14 3:54 pm Purchase | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 361,041 13.100% | 20,000 (+5.86%) | Filing History |
| 2022-02-11 4:57 pm Unchanged | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-01-27 11:04 am Sale | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Davidson Matt | 56,073 2.040% | -88,427 (-61.20%) | Filing History |
| 2021-02-16 8:57 pm Purchase | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 341,041 13.200% | 341,041 (New Position) | Filing History |
| 2021-02-16 4:04 pm Purchase | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 983,775 38.000% | 19,450 (+2.02%) | Filing History |
| 2021-02-16 3:47 pm Sale | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 0 0.000% | -341,041 (Position Closed) | Filing History |